After the National Institutes of Health (NIH) announced late Friday that it would be following a Trump administration ...

A temporally resolved CRISPR-Cas9 screen reveals DAC-induced DNA damage drives trans-cell cycle cytotoxicity that depends on ...

GeneDx is targeting a big market for its genetic testing: every newborn baby. The 24-old-company is developing a plan to make the testing common at birth.

Pacific Biosciences of California, Inc.’s PACB share price has dipped by 14.74%, which has investors questioning if this is right time to buy.

HOURS and correspondent Peter Van Sant report on the case in “It’s About Danni,” airing Saturday, February 8, 2025, on CBS ...

Next-generation sequencing tests offer potential for more precise remission determination, but technical and financial barriers exist. Cost-effectiveness and payer acceptance are essential for ...

Researchers at the University of Toronto have invented a new method that uses DNA sequencing to measure metabolites. This ...

Researchers studying gene expression have access to vast amounts of data from cells or tissues. This is thanks to advances in ...

Akribion Therapeutics ("Akribion"), the early-stage biotech developing a unique, RNA-guided, nuclease-based technology for programmable cell depletion, today announces its exit from stealth and the ...

This study introduced an ML-guided enzyme engineering platform that integrates cell-free DNA assembly, gene expression, and ...

Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, State Key Laboratory for Digestive Health, National Clinical Research Center for Digestive Disease, Beijing ...

The most complex engineering of human cell lines ever has been achieved by scientists, revealing that our genomes are more resilient to significant structural changes than was previously thought.